Porsolt and JSW Sign Research Services Deal

Porsolt and JSW announced that they have signed a strategic collaboration agreement to co-market complementary contract research services.

Porsolt and JSW Lifesciences have signed a collaboration agreement to co-market complementary contract research services.

As part of the agreement, Porsolt and JSW will co-market services to the Pharmaceutical and Biotech industries. The two companies will collaborate to provide expanded capabilities that build on the core expertise of each business.

"We are excited about working with Porsolt, a leading CRO with a global reputation and presence in numerous different markets. This agreement allows us to combine contract research services, proprietary disease models and technologies, drug discovery capabilities, and provide an expanded portfolio of services for the benefit of the pharma, biotech and research communities,” said Dr. Manfred Windisch